Publicaciones en colaboración con investigadores/as de Hospital de Móstoles (23)

2024

  1. A system dynamics modelling and analytical framework for imported dengue outbreak surveillance and risk mapping

    Acta Tropica, Vol. 257

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

  2. Prone positioning in Covid-19 patients with acute respiratory distress syndrome and invasive mechanical ventilation

    Enfermeria Intensiva, Vol. 34, Núm. 2, pp. 80-89

2021

  1. Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis

    Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311

  2. Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E23-E28

2020

  1. AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis

    Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658

  2. Adaptation and validation of the ICU Mobility Scale in Spain

    Enfermeria Intensiva, Vol. 31, Núm. 3, pp. 131-146

  3. Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis

    JCR: Journal of Clinical Rheumatology

  4. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study

    Journal of Hematology and Oncology, Vol. 13, Núm. 1

2015

  1. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

2014

  1. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

  2. Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir

    AIDS

2013

  1. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD)

    Respiratory Medicine, Vol. 107, Núm. 5, pp. 724-731

2011

  1. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849

2010

  1. Infección por el VIH en el adulto: cambios epidemiológicos durante 25 años (1983-2008) en un área de la Comunidad de Madrid

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 3, pp. 156-161

2009

  1. Cystatin C is associated with the metabolic syndrome and other cardiovascular risk factors in a hypertensive population

    Journal of the American Society of Hypertension, Vol. 3, Núm. 3, pp. 201-209

  2. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 50, Núm. 2, pp. 148-152

2008

  1. Biostatistics: A fundamental tool for the elaboration of radiological articles

    Radiologia, Vol. 50, Núm. 4, pp. 265-270

2007

  1. Economic evaluation of assistance to HIV patients in a Spanish hospital

    European Journal of Internal Medicine, Vol. 18, Núm. 5, pp. 400-404

2005

  1. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 800-804